首页 | 本学科首页   官方微博 | 高级检索  
     


Implementing a Screening Tool for Identifying Patients at Risk for Hereditary Breast and Ovarian Cancer: A Statewide Initiative
Authors:L. Brannon Traxler MD  Monique L. Martin MPH  CHES  Alice S. Kerber MN  APRN   APNG  Cecelia A. Bellcross PhD  MS   CGC  Barbara E. Crane MN  APRN  Victoria Green MD  JD   MHSA  MBA  Roland Matthews MD  Nancy M. Paris MS  FACHE  Sheryl G. A. Gabram MD  MBA
Affiliation:1. Department of Surgery, Emory University, Atlanta, GA, USA
2. Georgia Center for Oncology Research and Education, Atlanta, GA, USA
3. Department of Human Genetics, Emory University, Atlanta, GA, USA
4. Georgia Department of Public Health, Atlanta, GA, USA
5. Department of Obstetrics and Gynecology, Emory University, Atlanta, GA, USA
6. Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, USA
7. Grady Memorial Hospital, Atlanta, GA, USA
Abstract:

Background

The Georgia Breast Cancer Genomic Health Consortium is a partnership created with funding from the Centers for Disease Control and Prevention (CDC) to the Georgia Department of Public Health to reduce cancer disparities among high-risk minority women. The project addresses young women at increased risk for hereditary breast and ovarian cancer (HBOC) syndrome through outreach efforts.

Methods

The consortium provides education and collects surveillance data using the breast cancer genetics referral screening tool (B-RST) available at www.BreastCancerGeneScreen.org. The HBOC educational protocol was presented to 73 staff in 6 public health centers. Staff used the tool during the collection of medical history. Further family history assessments and testing for mutations in the BRCA1/2 genes were facilitated if appropriate.

Results

Data was collected from November 2012 through December 2013, including 2,159 screened women. The majority of patients identified as black/African American and were 18–49 years old. Also, 6.0 % (n = 130) had positive screens, and 60.9 % (n = 67) of the 110 patients who agreed to be contacted provided a detailed family history. A total of 47 patients (42.7 %) met National Comprehensive Cancer Network guidelines when family history was clarified. Fourteen (12.7 %) underwent genetic testing; 1 patient was positive for a BRCA2 mutation, and 1 patient was found to carry a variant of uncertain significance.

Conclusions

The introduction of genomics practice within public health departments has provided access to comprehensive cancer care for uninsured individuals. The successful implementation of the B-RST into public health centers demonstrates the opportunity for integration of HBOC screening into primary care practices.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号